Skip to main content

Edward Nash

Stock Analyst at Canaccord Genuity

Total Price Targets
7
Stocks Covered
4
Sectors
Healthcare
Most Recent
Jan 2, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • VKTX+203.5%
    Viking Therapeutics, Inc.
    $106.00 targetOct 29, 2025
  • CORT+168.3%
    Corcept Therapeutics Incorporated
    $99.00 targetJan 2, 2026
  • VKTX+163.5%
    Viking Therapeutics, Inc.
    $107.00 targetNov 12, 2025

Most Bearish

  • MDGL+33.1%
    Madrigal Pharmaceuticals, Inc.
    $420.00 targetMay 2, 2025
  • VKTX+163.5%
    Viking Therapeutics, Inc.
    $107.00 targetNov 12, 2025
  • CORT+168.3%
    Corcept Therapeutics Incorporated
    $99.00 targetJan 2, 2026

Stocks Covered by Edward Nash

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
CORTCorcept Therapeutics Incorporated$99.00$51.08+93.8%3Jan 2, 2026
VKTXViking Therapeutics, Inc.$107.00$29.80+259.0%2Nov 12, 2025
MDGLMadrigal Pharmaceuticals, Inc.$420.00$516.66-18.7%1May 2, 2025
RANIRani Therapeutics Holdings, Inc.$9.00$0.94+857.6%1Mar 27, 2024

Recent Activity

  • Jan 2, 2026— Set$99.00price target onCORT(Corcept Therapeutics Incorporated)
  • Nov 12, 2025— Set$107.00price target onVKTX(Viking Therapeutics, Inc.)
  • Oct 29, 2025— Set$106.00price target onVKTX(Viking Therapeutics, Inc.)
  • May 2, 2025— Set$420.00price target onMDGL(Madrigal Pharmaceuticals, Inc.)
  • Aug 15, 2024— Set$78.00price target onCORT(Corcept Therapeutics Incorporated)
  • Jun 12, 2024— Set$38.00price target onCORT(Corcept Therapeutics Incorporated)
  • Mar 27, 2024— Set$9.00price target onRANI(Rani Therapeutics Holdings, Inc.)

Frequently Asked Questions

Who is Edward Nash?

Edward Nash is a stock analyst at Canaccord Genuity covering 4 stocks primarily in Healthcare. They have issued 7 price targets since Mar 27, 2024.

What stocks does Edward Nash cover?

Edward Nash currently covers 4 stocks, including CORT, VKTX, MDGL, RANI.

What is Edward Nash's latest price target?

Edward Nash's most recent price target was $99.00 on CORT (Corcept Therapeutics Incorporated), set on Jan 2, 2026.

What is Edward Nash's highest price target?

Edward Nash's highest issued price target is $420.00 on MDGL, set on May 2, 2025.

Coverage based on publicly published price targets. Not investment advice.